(Updates)
** Skin treatment devices maker Beauty Health's SKIN.O
shares fall ~60% to $1.60, hitting record low
** Co reports CEO Andrew Stanleick's to depart from SKIN,
effective Nov. 19 and cuts FY23 sales forecast
** Marla Beck to serve as interim CEO as co seeks for a
replacement
** Co posts downbeat Q3 U.S. revenue and incurs $63.1 mln in
restructuring charges for device upgrades
** Co managing through issue with its clogged digital Syndeo
delivery machines, will only market and sell a 3.0 version of
the system
** Cuts FY23 sales forecast to $385 mln-$400 mln, from $460
mln-$480 mln and withdraws FY25 targets
** To provide customers options of a upgrade to earlier
device versions or a replacement for existing devices - company
** At least 3 brokerage cut stock PT post results
** Co posts Q3 revenue of $97.4 mln, missing analysts'
estimate of $116.20 mln, per LSEG data
** Including sessions fall, stock down 82.9% YTD
(Reporting by Pratik Jain and Pranav Kashyap in Bengaluru)
((Pratik.Jain@thomsonreuters.com;))